Drug Profile
Research programme: antifungal vaccines - HiberCell/California Institute for Medical Research
Alternative Names: Antifungal vaccine - HiberCellLatest Information Update: 15 Jan 2021
Price :
$50
*
At a glance
- Originator Biothera; California Institute for Medical Research
- Class Conjugate vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Aspergillosis; Coccidioidomycosis; Mycoses
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for preclinical development in Aspergillosis in USA (Parenteral)
- 28 Sep 2018 No recent reports of development identified for preclinical development in Coccidioidomycosis in USA (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Mycoses in USA (Parenteral)